Predicting sepsis severity at first clinical presentation: The role of endotypes and mechanistic signatures

被引:108
作者
Baghela, Arjun [1 ,2 ]
Pena, Olga M. [1 ]
Lee, Amy H. [3 ]
Baquir, Beverlie [1 ]
Falsafi, Reza [1 ]
An, Andy [1 ]
Farmer, Susan W. [1 ]
Hurlburt, Andrew [4 ]
Mondragon-Cardona, Alvaro [5 ,6 ]
Rivera, Juan Diego [5 ,6 ]
Baker, Andrew [7 ]
Trahtemberg, Uriel [7 ]
Shojaei, Maryam [8 ]
Jimenez-Canizales, Carlos Eduardo [5 ,6 ]
dos Santos, Claudia C. [7 ]
Tang, Benjamin [8 ]
Bouma, Hjalmar R. [9 ,10 ]
Freue, Gabriela V. Cohen [11 ]
Hancock, Robert E. W. [1 ]
机构
[1] Univ British Columbia, Ctr Microbial Dis & Immun Res, 232-2259 Lower Mall, Vancouver, BC V5T 4S6, Canada
[2] Genome Sci Ctr, Bioinformat Grad Program, 570 W 7th Ave, Vancouver, BC V5T 4S6, Canada
[3] Simon Fraser Univ, Dept Mol Biol & Biochem, 8888 Univ Dr, Burnaby, BC V5A 1S6, Canada
[4] Vancouver Gen Hosp, 899 W 12th Ave, Vancouver, BC V5Z 1M9, Canada
[5] Hosp Univ Hernando Moncaleano, Calle 9 15-25, Neiva, Colombia
[6] Univ Surcolombiana, Dept Internal Med, Calle 9 Carrera 14, Neiva, Colombia
[7] Univ Toronto, Keenan Res Ctr Biomed Sci, Crit Care Med, St Michaels Hosp, 30 Bond St, Toronto, ON M5G 1W8, Canada
[8] Westmead Inst Med Res, 176 Hawkesbury Rd, Westmead, NSW 2145, Australia
[9] Univ Groningen, Dept Internal Med, Univ Med Ctr Groningen, Hanzepl 1, NL-9713 AV Groningen, Netherlands
[10] Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Hanzepl 1, NL-9713 AV Groningen, Netherlands
[11] Univ British Columbia, Dept Stat, 2207 Main Mall, Vancouver, BC V6T 1Z4, Canada
关键词
Sepsis; Severe sepsis; Endotypes; Gene signatures & biomarkers; Cellular reprogramming; Translational medicine; DEFINITIONS; OUTCOMES;
D O I
10.1016/j.ebiom.2021.103776
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Inter-individual variability during sepsis limits appropriate triage of patients. Identifying, at first clini-cal presentation, gene expression signatures that predict subsequent severity will allow clinicians to identify the most at-risk groups of patients and enable appropriate antibiotic use. Methods Blood RNA-Seq and clinical data were collected from 348 patients in four emergency rooms (ER) and one intensive-care-unit (ICU), and 44 healthy controls. Gene expression profiles were analyzed using machine learning and data mining to identify clinically relevant gene signatures reflecting disease severity, organ dysfunction, mortal-ity, and specific endotypes/mechanisms. Findings Gene expression signatures were obtained that predicted severity/organ dysfunction and mortality in both ER and ICU patients with accuracy/AUC of 77-80%. Network analysis revealed these signatures formed a coherent biological program, with specific but overlapping mechanisms/pathways. Given the heterogeneity of sepsis, we asked if patients could be assorted into discrete groups with distinct mechanisms (endotypes) and varying severity. Patients with early sepsis could be stratified into five distinct and novel mechanistic endotypes, named Neutrophilic-Suppressive/NPS, Inflammatory/INF, Innate-Host-Defense/IHD, Interferon/IFN, and Adaptive/ADA, each based on similar to 200 unique gene expression differences, and distinct pathways/mechanisms (e.g., IL6/STAT3 in NPS). Endo-types had varying overall severity with two severe (NPS/INF) and one relatively benign (ADA) groupings, consistent with reanalysis of previous endotype studies. A 40 gene-classification tool (accuracy=96%) and several gene-pairs (accuracy=89-97%) accurately predicted endotype status in both ER and ICU validation cohorts. Interpretation The severity and endotype signatures indicate that distinct immune signatures precede the onset of severe sepsis and lethality, providing a method to triage early sepsis patients. Copyright (C) 2021 The Authors. Published by Elsevier B.V.
引用
收藏
页数:15
相关论文
共 44 条
[1]   Identifying Novel Sepsis Subphenotypes Using Temperature Trajectories [J].
Bhavani, Sivasubramanium, V ;
Carey, Kyle A. ;
Gilbert, Emily R. ;
Afshar, Majid ;
Verhoef, Philip A. ;
Churpek, Matthew M. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 200 (03) :327-335
[2]  
Billi AC, 2020, SCI T MED, V12
[3]   DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS [J].
BONE, RC ;
BALK, RA ;
CERRA, FB ;
DELLINGER, RP ;
FEIN, AM ;
KNAUS, WA ;
SCHEIN, RMH ;
SIBBALD, WJ .
CHEST, 1992, 101 (06) :1644-1655
[4]  
Chen BB, 2018, METHODS MOL BIOL, V1711, P243, DOI 10.1007/978-1-4939-7493-1_12
[5]  
Chiesa M, 2020, SCI REP-UK, V10, P1
[6]  
Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI [10.1093/nar/gkt1102, 10.1093/nar/gkz1031]
[7]   Genomic landscape of the individual host response and outcomes in sepsis: a prospective cohort study [J].
Davenport, Emma E. ;
Burnham, Katie L. ;
Radhakrishnan, Jayachandran ;
Humburg, Peter ;
Hutton, Paula ;
Mills, Tara C. ;
Rautanen, Anna ;
Gordon, Anthony C. ;
Garrard, Christopher ;
Hill, Adrian V. S. ;
Hinds, Charles J. ;
Knight, Julian C. .
LANCET RESPIRATORY MEDICINE, 2016, 4 (04) :259-271
[8]   Marked alterations of neutrophil functions during sepsis-induced immunosuppression [J].
Demaret, Julie ;
Venet, Fabienne ;
Friggeri, Arnaud ;
Cazalis, Marie-Angelique ;
Plassais, Jonathan ;
Jallades, Laurent ;
Malcus, Christophe ;
Poitevin-Later, Francoise ;
Textoris, Julien ;
Lepape, Alain ;
Monneret, Guillaume .
JOURNAL OF LEUKOCYTE BIOLOGY, 2015, 98 (06) :1081-1090
[9]   Sepsis: pathophysiology and clinical management [J].
Gotts, Jeffrey E. ;
Matthay, Michael A. .
BMJ-BRITISH MEDICAL JOURNAL, 2016, 353
[10]   GSVA: gene set variation analysis for microarray and RNA-Seq data [J].
Haenzelmann, Sonja ;
Castelo, Robert ;
Guinney, Justin .
BMC BIOINFORMATICS, 2013, 14